Oracle Alpha »

Cytokinetics shares owned by Oracle Alpha

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Oracle Alpha from 13F filings

Historical chart of Oracle Alpha investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Oracle Alpha consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Oracle Alpha

Quarter filed Position value Share count Share price at filing
2023-12-31 $518k 6.2k 83.49

More positions owned by Oracle Alpha

Micron Technology (MU)
Coinbase Global (COIN)
Eli Lilly & Co. (LLY)
Intel Corporation (INTC)
NVIDIA Corporation (NVDA)
Macy's (M)
Samsara (IOT)
Applied Materials (AMAT)
Synchrony Financial (SYF)
Gitlab (GTLB)
Ptc Therapeutics I (PTCT)
Netflix (NFLX)
Johnson & Johnson (JNJ)
Regeneron Pharmaceuticals (REGN)
Thermo Fisher Scientific (TMO)

View all positions for Oracle Alpha

Top funds holding Cytokinetics

BlackRock
FMR
Vanguard Group
Wellington Management Company
Bank of America Corporation
T. Rowe Price Investment Management
T. Rowe Price Associates
Marshall Wace
Pentwater Capital Management
Geode Capital Management
Armistice Capital
HAP Trading
Susquehanna International
Boxer Capital
Melqart Asset Management

View all funds holding Cytokinetics